Ambroxol + Levosalbutamol + Guaifenesin Drop | PCD Pharma Franchise in Hyderabad

Cough Relief Drop | Pediatric Pharma Manufacturing Company in Mumbai

Ambroxol Levosalbutamol Guaifenesin Drop | Pediatric Pharma Franchise in Pune

Pediatric Respiratory Drops | Pharma Suppliers in Delhi

Ambroxol Levosalbutamol Guaifenesin Drops | Pharma Export Companies in Kolkata
Pediatric Cold & Cough Drops | Pharma Franchise Opportunities in Bengaluru

Home/Products /ambroxol-7-point-5mg-ml-levosalbutamol-12-point-5mg-ml-drop

About the Product

Description


Cufstik LS Drop is a pediatric respiratory solution formulated to provide effective relief from chest congestion and productive cough in infants and young children. Ambroxol acts as a mucolytic to break down thick mucus, Levosalbutamol serves as a bronchodilator to ease breathing by relaxing the airway muscles, and Guaifenesin functions as an expectorant to clear phlegm from the respiratory tract. This combination works synergistically to alleviate symptoms associated with respiratory tract infections, enhance airway clearance, and improve breathing comfort in pediatric patients.

Cufstik LS Drop is generally safe when used as prescribed. Some children may experience mild side effects such as nausea, upset stomach, dry mouth, or restlessness. In rare cases, allergic reactions may occur and should be reported immediately.

Cufstik LS Drop is indicated for the treatment of wet or productive cough in children, especially in conditions involving thick mucus and chest congestion. It is beneficial in managing respiratory tract infections, bronchitis, and coughs associated with allergies or seasonal changes. The formulation helps loosen mucus, clear airways, and promote comfortable breathing in pediatric patients.

Use only under the guidance of a healthcare professional. Shake well before use. Dosage should be administered based on the child’s age and body weight.

Store at room temperature (20°C to 25°C), away from direct light, heat, and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ambroxol 7.5mg/ml + Levosalbutamol 12.5mcg/ml Drops in the PCD pharma franchise market?

This respiratory drop formulation has strong demand in the pediatric and neonatal care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on infant respiratory care portfolios.

Why should medical distributors include this combination drop in their product range?

Medical distributors and agencies can benefit from consistent demand for respiratory therapy used in wheezing, bronchitis, chest congestion, productive cough, and breathing difficulty in infants and children. Ambroxol helps loosen mucus for easier expulsion, while Levosalbutamol relaxes airway muscles to improve breathing, strengthening a pediatric respiratory care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this respiratory drop formulation with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong pediatric prescription demand, seasonal respiratory usage, fast-moving pediatric respiratory category, reliable supply chain support, and good margins when partnering for this product.

How can I become a distributor or franchise partner for this drop formulation?

Medical distributors, stockists, and wholesalers interested in this combination respiratory drop can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.